title: Targeted Therapies for the Treatment of Brain Metastases in Solid Tumors.
abstract: Brain metastases are a major cause of morbidity and mortality in cancer patients. While the mainstay treatment comprises surgery and radiation therapy, the role of systemic agents remains controversial. In general, it has been presumed that poor blood-brain barrier (BBB) penetration and inherently more resistant metastatic brain disease preclude a favorable systemic treatment approach. However, a better understanding of tumor biology and the subsequent development of targeted drugs have reawakened interest in systemic therapy. Despite still limited brain distribution, a variety of targeted drugs have demonstrated activity in brain metastases in early clinical trials. Nevertheless, disease progression commonly occurs, and it remains to be elucidated whether limited CNS drug distribution or the acquisition of resistant metastatic clones must be held responsible for this prognosis. Moreover, micrometastatic brain disease beyond an intact BBB-and ultimately prevention of brain metastasis formation-may generally remain inaccessible for first-generation targeted agents with poor CNS penetration. To overcome limited brain distribution and possibly emerging acquired resistance, highly potent next-generation targeted drugs with enhanced CNS distribution have been developed. In view of this emerging but yet undefined role of targeted therapies in the treatment of brain metastases from solid tumors, this review aims to summarize the current knowledge from clinical trials and discusses clinically relevant obstacles to overcome.
authors.affiliation: Department of Internal Medicine V, Medical University of Innsbruck, Anichstrasse 35, A-6020, Innsbruck, Austria. Jan-Paul.Bohn@i-med.ac.at.
authors.forename: Jan-Paul
authors.initials: JP
authors.lastname: Bohn
authors.affiliation: Department of Internal Medicine V, Medical University of Innsbruck, Anichstrasse 35, A-6020, Innsbruck, Austria.
authors.forename: Georg
authors.initials: G
authors.lastname: Pall
authors.affiliation: Department of Neurology and Neurosurgery, Medical University of Innsbruck, Innsbruck, Austria.
authors.forename: Guenther
authors.initials: G
authors.lastname: Stockhammer
authors.affiliation: Department of Internal Medicine V, Medical University of Innsbruck, Anichstrasse 35, A-6020, Innsbruck, Austria.
authors.forename: Michael
authors.initials: M
authors.lastname: Steurer
mesh_terms: D001932:Brain Neoplasms / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D009362:Neoplasm Metastasis; D011379:Prognosis
references.citation: N Engl J Med. 2015 Apr 30;372(18):1700-9
references.pmid: 25923550
references.citation: N Engl J Med. 2015 Jan 1;372(1):30-9
references.pmid: 25399551
references.citation: Clin Cancer Res. 2006 Nov 1;12(21):6494-501
references.pmid: 17085664
references.citation: Cochrane Database Syst Rev. 2012 Apr 18;(4):CD003869
references.pmid: 22513917
references.citation: Cancer Res. 2004 Oct 1;64(19):7099-109
references.pmid: 15466206
references.citation: Cancer Res. 2005 Apr 15;65(8):3328-35
references.pmid: 15833866
references.citation: Clin Oncol (R Coll Radiol). 2013 Mar;25(3):e23-30
references.pmid: 23211715
references.citation: J Clin Oncol. 2013 Sep 20;31(27):3335-41
references.pmid: 23816963
references.citation: Lancet Oncol. 2014 Sep;15(10):1119-28
references.pmid: 25153538
references.citation: J Natl Cancer Inst. 2014 Jul 16;106(7):null
references.pmid: 25031274
references.citation: Nat Rev Clin Oncol. 2014 Apr;11(4):203-22
references.pmid: 24569448
references.citation: J Thorac Oncol. 2011 Jul;6(7):1287-9
references.pmid: 21847041
references.citation: Cancer Res. 1999 Aug 15;59(16):4129-35
references.pmid: 10463618
references.citation: J Clin Oncol. 2009 Nov 1;27(31):5255-61
references.pmid: 19738122
references.citation: J Pharmacol Exp Ther. 2012 Nov;343 (2):342-50
references.pmid: 22888144
references.citation: Eur J Cancer. 2014 Feb;50(3):611-21
references.pmid: 24295639
references.citation: Acad Radiol. 2005 Oct;12(10):1232-40
references.pmid: 16179200
references.citation: Cancer. 2012 Aug 15;118(16):4014-23
references.pmid: 22180178
references.citation: Clin Cancer Res. 2009 Feb 15;15(4):1452-9
references.pmid: 19228746
references.citation: N Engl J Med. 2014 Dec 4;371(23):2167-77
references.pmid: 25470694
references.citation: Lancet Oncol. 2012 Nov;13(11):1087-95
references.pmid: 23051966
references.citation: J Thorac Oncol. 2015 Jan;10 (1):156-63
references.pmid: 25247337
references.citation: Biochem Pharmacol. 2012 Aug 1;84(3):260-7
references.pmid: 22548830
references.citation: Drug Metab Dispos. 2014 Aug;42(8):1292-300
references.pmid: 24875464
references.citation: Clin Cancer Res. 2007 Nov 15;13(22 Pt 1):6555-60
references.pmid: 18006754
references.citation: Science. 2005 Jan 7;307(5706):58-62
references.pmid: 15637262
references.citation: J Clin Oncol. 2004 Jul 15;22(14):2865-72
references.pmid: 15254054
references.citation: Clin Cancer Res. 2012 Aug 15;18(16):4406-14
references.pmid: 22733536
references.citation: J Clin Oncol. 2005 Feb 10;23 (5):1028-43
references.pmid: 15534359
references.citation: Nature. 2002 Jun 27;417(6892):949-54
references.pmid: 12068308
references.citation: Cancer Res. 2000 Aug 1;60(15):4251-5
references.pmid: 10945638
references.citation: N Engl J Med. 2005 Nov 17;353(20):2135-47
references.pmid: 16291983
references.citation: J Clin Oncol. 2013 Mar 1;31(7):895-902
references.pmid: 23341526
references.citation: Ann Oncol. 2014 Apr;25(4):912-3
references.pmid: 24667724
references.citation: J Neurooncol. 2010 Jan;96(1):71-83
references.pmid: 19960229
references.citation: Science. 1987 Jan 9;235(4785):177-82
references.pmid: 3798106
references.citation: Cancer Res. 2001 Oct 1;61(19):7196-203
references.pmid: 11585755
references.citation: Mol Pharm. 2012 Nov 5;9(11):3236-45
references.pmid: 23020847
references.citation: Cell. 2014 Feb 27;156(5):1002-16
references.pmid: 24581498
references.citation: J Clin Oncol. 2008 Apr 20;26(12):1993-9
references.pmid: 18421051
references.citation: Nat Rev Neurosci. 2006 Jan;7(1):41-53
references.pmid: 16371949
references.citation: Neurosurgery. 2004 Jan;54(1):131-40; discussion 141-2
references.pmid: 14683550
references.citation: Neoplasia. 2011 Mar;13(3):286-98
references.pmid: 21390191
references.citation: Pharm Res. 2012 Mar;29(3):770-81
references.pmid: 22011930
references.citation: J Clin Oncol. 2015 Jun 10;33(17):1881-8
references.pmid: 25624436
references.citation: Cell. 1990 Jun 29;61(7):1339-47
references.pmid: 1973074
references.citation: Cell. 2011 Mar 4;144(5):646-74
references.pmid: 21376230
references.citation: Cancer Metastasis Rev. 1991 Dec;10(4):335-41
references.pmid: 1786634
references.citation: N Engl J Med. 2011 Feb 24;364(8):772-4
references.pmid: 21345109
references.citation: Lancet Oncol. 2012 May;13(5):528-38
references.pmid: 22452896
references.citation: J Biol Chem. 1999 Mar 26;274(13):8865-74
references.pmid: 10085130
references.citation: Cancer. 2011 Feb 1;117(3):501-9
references.pmid: 20862748
references.citation: Am J Pathol. 1992 Nov;141(5):1115-24
references.pmid: 1443046
references.citation: Cancer Invest. 1990;8(3-4):327-34
references.pmid: 2207757
references.citation: J Natl Cancer Inst. 2006 Mar 1;98(5):326-34
references.pmid: 16507829
references.citation: Semin Cancer Biol. 2011 Apr;21(2):107-12
references.pmid: 21167939
references.citation: J Neurooncol. 2011 Dec;105(3):613-20
references.pmid: 21706359
references.citation: J Pharmacol Exp Ther. 2013 Mar;344(3):655-64
references.pmid: 23249624
references.citation: N Engl J Med. 2015 Apr 30;372(18):1689-99
references.pmid: 25923549
references.citation: Clin Cancer Res. 2015 Apr 15;21(8):1851-8
references.pmid: 25700303
references.citation: J Clin Oncol. 2010 Jul 10;28(20):3271-7
references.pmid: 20498394
references.citation: J Neurooncol. 2013 Jul;113(3):411-6
references.pmid: 23579338
references.citation: Nat Rev Neurosci. 2007 Aug;8(8):610-22
references.pmid: 17643088
references.citation: Neurol Sci. 2014 Apr;35(4):507-14
references.pmid: 24442487
references.citation: Lung Cancer. 2012 Sep;77(3):556-60
references.pmid: 22677429
references.citation: Oncotarget. 2015 Feb 28;6(6):4527-36
references.pmid: 25784657
references.citation: J Pharmacol Exp Ther. 2011 Jan;336(1):223-33
references.pmid: 20952483
references.citation: Clin Cancer Res. 2007 Mar 15;13(6):1663-74
references.pmid: 17363519
references.citation: Clin Cancer Res. 2010 Jan 1;16(1):269-78
references.pmid: 20028762
references.citation: J Neurooncol. 2014 Oct;120(1):147-54
references.pmid: 25098698
references.citation: Ann Oncol. 2010 May;21(5):1027-31
references.pmid: 19850637
references.citation: Curr Treat Options Neurol. 2014 Jan;16(1):276
references.pmid: 24353011
references.citation: Drug Metab Dispos. 2009 Feb;37(2):439-42
references.pmid: 19056914
references.citation: J Clin Oncol. 2007 Jun 1;25(16):2306-12
references.pmid: 17538177
references.citation: Clin Cancer Res. 2010 Dec 1;16(23):5873-82
references.pmid: 21030498
references.citation: N Engl J Med. 2013 Jun 20;368(25):2385-94
references.pmid: 23724913
references.citation: N Engl J Med. 2014 Mar 27;370(13):1189-97
references.pmid: 24670165
references.citation: Lancet Oncol. 2015 Dec;16(16):1700-10
references.pmid: 26596672
references.citation: N Engl J Med. 2010 Oct 28;363(18):1693-703
references.pmid: 20979469
references.citation: Cancer. 1999 Apr 1;85(7):1599-605
references.pmid: 10193952
references.citation: Neuro Oncol. 2011 Dec;13(12):1364-9
references.pmid: 21865399
references.citation: Cancer Discov. 2014 Jan;4(1):80-93
references.pmid: 24265155
references.citation: Nat Rev Cancer. 2010 Nov;10(11):760-74
references.pmid: 20966921
references.citation: Cancer. 1996 Oct 15;78(8):1781-8
references.pmid: 8859192
references.citation: Pract Radiat Oncol. 2012 Jul-Sep;2(3):210-25
references.pmid: 25925626
references.citation: Cancer Discov. 2014 Jan;4(1):94-109
references.pmid: 24265153
references.citation: Cancer Treat Rev. 2004 Feb;30(1):1-17
references.pmid: 14766123
references.citation: EMBO J. 1997 Apr 1;16(7):1647-55
references.pmid: 9130710
references.citation: Cancer Metastasis Rev. 2013 Dec;32(3-4):567-84
references.pmid: 23584575
references.citation: N Engl J Med. 2013 Aug 22;369(8):722-31
references.pmid: 23964934
references.citation: Cancer Res. 2001 Aug 15;61(16):6020-4
references.pmid: 11507045
references.citation: Cancer Discov. 2015 Nov;5(11):1164-1177
references.pmid: 26410082
references.citation: J Pharmacol Exp Ther. 2013 Sep;346(3):486-94
references.pmid: 23843632
references.citation: Int J Radiat Oncol Biol Phys. 1994 Jun 15;29(3):427-31
references.pmid: 8005794
references.citation: N Engl J Med. 2014 Nov 13;371(20):1867-76
references.pmid: 25265494
references.citation: J Thorac Oncol. 2010 Jul;5(7):950-5
references.pmid: 20479691
references.citation: J Clin Oncol. 2006 Sep 20;24(27):4517-20
references.pmid: 16983123
references.citation: Lancet Oncol. 2013 Jan;14(1):64-71
references.pmid: 23122784
references.citation: Mol Pharmacol. 2012 Jul;82(1):47-58
references.pmid: 22491935
references.citation: Clin Cancer Res. 1999 Oct;5(10):2884-90
references.pmid: 10537357
references.citation: J Clin Oncol. 2016 Mar 20;34(9):945-52
references.pmid: 26834058
references.citation: Clin Cancer Res. 2015 Apr 15;21(8):1896-903
references.pmid: 25614446
references.citation: EJNMMI Res. 2015 Apr 30;5:30
references.pmid: 25977884
references.citation: J Pharmacol Exp Ther. 2012 Jul;342(1):33-40
references.pmid: 22454535
references.citation: Nature. 2007 Aug 2;448(7153):561-6
references.pmid: 17625570
references.citation: Cancer. 2010 Mar 1;116(5):1272-80
references.pmid: 20082451
references.citation: J Neurooncol. 2010 Sep;99(2):283-6
references.pmid: 20146086
references.citation: J Clin Oncol. 2011 May 20;29(15):e443-5
references.pmid: 21422405
references.citation: Target Oncol. 2010 Dec;5(4):245-55
references.pmid: 20574858
references.citation: Mol Pharm. 2014 Nov 3;11(11):4199-207
references.pmid: 25243894